Study types
- article 5
- review 2
- editorial 1
- meta-analysis 1
- other 1
Condition tags
- endometriosis 7
- dysmenorrhea 3
- adenomyosis 2
- infertility 1
- endometrioma 1
- die_deep_infiltrating 1
Top journals
Frequent coauthors
BACKGROUND: OHVIRA syndrome, a urogenital malformation, lacks standardized management. Narrative reviews exist, but there is no a comprehensive meta-analysis. OBJECTIVES: The aim of this first systematic review and meta-analysis is to eval…
Background/Objectives: To evaluate the clinicopathological features, treatment, and survival outcomes and to identify independent prognosticators for recurrence and mortality in patients with endometrioid ovarian cancer. Methods: The medica…
Background: Desmoid tumors (DTs) are rare, locally aggressive soft-tissue neoplasms that often affect women of reproductive age. Pregnancy and prior abdominal surgery or trauma have been associated with tumor development and growth, while i…
BACKGROUND: Almost 10% of women in reproductive age are diagnosed with ovarian endometriomas and can experience symptoms and infertility disorders. Ovarian endometriomas can be treated with medical or surgical therapy. OBJECTIVE: To assess …
Endometriosis is a chronic debilitating disease that affects nearly 10% of women of the reproductive age. Although the treatment modalities of endometriosis are numerous, surgical excision of the endometriotic implants and nodules remains t…
Molecular and cellular research in the field of endometriosis is moving forward in giant steps [...].
AIM: The scar of cesarean section (CS) is the most common site of abdominal wall endometriosis (AWE), whose tumor degeneration has been reported in an increasing number of cases; the most frequent histological type is clear cell carcinoma (…
Introduction: Parametrial endometriosis could often involve the ureter and periureteral tissue causing hydronephrosis and distortion of the normal ureteral course and position. The treatment in the case of hydronephrosis could be ureterolys…
Poster: ECR 2015 / C-0975 / Study of imaging and clinical outcome in uterine adenomyosis MRGFUS treatment: 2 years follow up by: Ferrari, A. Miccoli, F. Arrigoni, E. Fascetti, G. Mascaretti, C. Masciocchi; L'Aquila/IT